Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Jazz Pharmaceuticals plc - Company Profile (NASDAQ:JAZZ)

Consensus Ratings for Jazz Pharmaceuticals plc - (NASDAQ:JAZZ) (?)
Ratings Breakdown: 6 Hold Rating(s), 13 Buy Rating(s), 1 Strong Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $171.67 (22.86% upside)

Current Analysts' Coverage Summary for Jazz Pharmaceuticals plc - (NASDAQ:JAZZ)
Show:
DateFirmActionRatingPrice TargetDetailsShare
7/29/2014Leerink SwannBoost Price TargetOutperform$171.00 -> $177.00ViewTweet This Rating  Share This Rating on StockTwits
7/23/2014Buckingham ResearchInitiated CoverageBuy$215.00ViewTweet This Rating  Share This Rating on StockTwits
7/22/2014Deutsche BankInitiated CoverageBuy$176.00ViewTweet This Rating  Share This Rating on StockTwits
7/16/2014SunTrustInitiated CoverageNeutral$158.00ViewTweet This Rating  Share This Rating on StockTwits
7/2/2014FBR Capital MarketsReiterated RatingTop PickViewTweet This Rating  Share This Rating on StockTwits
6/20/2014ZacksReiterated RatingNeutral -> Neutral$157.00ViewTweet This Rating  Share This Rating on StockTwits
6/17/2014JMP SecuritiesInitiated CoverageOutperform$179.00ViewTweet This Rating  Share This Rating on StockTwits
6/10/2014Wells Fargo & Co.Initiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
5/27/2014Cantor FitzgeraldReiterated RatingHold$182.00 -> $151.00ViewTweet This Rating  Share This Rating on StockTwits
5/12/2014TheStreetDowngradeHoldViewTweet This Rating  Share This Rating on StockTwits
5/9/2014R. F. LaffertyLower Price TargetNeutral$140.00 -> $130.00ViewTweet This Rating  Share This Rating on StockTwits
5/9/2014Citigroup Inc.Lower Price TargetBuy$195.00 -> $165.00ViewTweet This Rating  Share This Rating on StockTwits
4/17/2014Canaccord GenuityInitiated CoverageBuy$163.00ViewTweet This Rating  Share This Rating on StockTwits
3/7/2014BarclaysInitiated CoverageOverweight$200.00ViewTweet This Rating  Share This Rating on StockTwits
2/26/2014Cowen and CompanyBoost Price Target$160.00 -> $190.00ViewTweet This Rating  Share This Rating on StockTwits
2/26/2014Brean CapitalBoost Price Target$171.00 -> $207.00ViewTweet This Rating  Share This Rating on StockTwits
2/26/2014Stifel NicolausBoost Price TargetBuy$145.00 -> $195.00ViewTweet This Rating  Share This Rating on StockTwits
2/26/2014Piper JaffrayBoost Price TargetOverweight$159.00 -> $201.00ViewTweet This Rating  Share This Rating on StockTwits
2/26/2014GuggenheimBoost Price TargetBuy$140.00 -> $210.00ViewTweet This Rating  Share This Rating on StockTwits
12/16/2013Goldman SachsDowngradeBuy -> Neutral$105.00 -> $123.00ViewTweet This Rating  Share This Rating on StockTwits
10/30/2013FBR & Co.Initiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
9/13/2013Lazard Capital MarketsReiterated RatingBuy$93.00ViewTweet This Rating  Share This Rating on StockTwits
2/27/2013WallachBeth CapitalBoost Price TargetBuy$63.00 -> $70.00ViewTweet This Rating  Share This Rating on StockTwits
2/25/2013Bank of AmericaInitiated CoverageBuy$74.00ViewTweet This Rating  Share This Rating on StockTwits
2/4/2013Lazard LtdReiterated RatingBuy$87.00ViewTweet This Rating  Share This Rating on StockTwits
9/28/2012OppenheimerReiterated RatingOutperform -> OutperformViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/31/2012 forward)